A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer

David J. Hunter(The University of Sydney), Stephen J. Chanock(National Cancer Institute), Michael J. Thun(American Cancer Society), Nilanjan Chatterjee(Johns Hopkins University), David G. Cox(Université Claude Bernard Lyon 1), Graham A. Colditz(Jewish Hospital), Richard B. Hayes(New York University), Susan E. Hankinson(University of Massachusetts Amherst), Heather Spencer Feigelson(Kaiser Permanente), Regina G. Ziegler(National Institutes of Health), Peter Kraft(National Cancer Institute), Catherine A. McCarty(University of Minnesota, Duluth), Nick Orr(United States Department of Health and Human Services), Saundra S. Buys(University of Utah), Kevin B. Jacobs(Emergent BioSolutions (United States)), Walter C. Willett(Harvard University), Amy Hutchinson(National Institutes of Health), Junwen Wang(National Institutes of Health), Kai Yu(National Institutes of Health), Zhaoming Wang(St. Jude Children's Research Hospital), Christine D. Berg(National Cancer Institute), Meredith Yeager(Frederick National Laboratory for Cancer Research), Gilles Thomas(Royal Marsden NHS Foundation Trust), Joseph F. Fraumeni(National Institutes of Health), Robert Welch(National Institutes of Health), Margaret A. Tucker(National Institutes of Health), Eugenia E. Calle(American Cancer Society), Sholom Wacholder(National Cancer Institute), Daniela S. Gerhard(United States Department of Health and Human Services), Robert N. Hoover(Tulane University)
Nature Genetics
May 27, 2007
Cited by 1,515


Related Papers